Riverstone Holdings

Glove makers and Medtecs International surge on possible new virus variant - THE EDGE SINGAPORE

Covid-19

Glove makers and Medtecs International surge on possible new virus variant

Nevertheless, these counters are still significantly off their peaks from last year.
Riverstone gets double take from analysts following 3Q2021 results - THE EDGE SINGAPORE

Broker's Calls

Riverstone gets double take from analysts following 3Q2021 results

Riverstone expected to give out higher dividends: DBS analyst Ling Lee Keng
Riverstone still sees strong 3Q results despite shift to ‘endemic’ Covid-19  - THE EDGE SINGAPORE

Results

Riverstone still sees strong 3Q results despite shift to 'endemic' Covid-19

Riverstone says demand for gloves continue to grow, but also notes that prices for examination gloves have begun to normalise.

In print this week

Hong Kong investor and EPF pare stake in Interra Resources, Riverstone respectively

Interra Resources has started drilling another well in Myanmar
Top Glove comes up tops; Riverstone scores for ROE - THE EDGE SINGAPORE

Billion Dollar Club 2021

Top Glove comes up tops; Riverstone scores for ROE

Top Glove comes out tops in the healthcare services and pharmaceuticals sector, while Riverstone Holdings delivers the best ROE.

Broker's Calls

Broker's Digest: AEM, Genting Singapore, Riverstone Holdings, Far East Orchard

See the analysts' recommendations and target prices here.
DBS, CGS-CIMB trim Riverstone TP as glove prices ease - THE EDGE SINGAPORE

Broker's Calls

DBS, CGS-CIMB trim Riverstone TP as glove prices ease

“We expect sequentially weaker results for the segment going forward, due to lower production volume and lower ASP."

Broker's Calls

RHB stays 'neutral' on Riverstone on downtrend in glove prices

RHB believes glove prices have peaked in 1Q21.

Results

Riverstone reports 656.8% earnings jump

Riverstone is expanding its capacity to 15 billion pieces per year by FY2023.
RHB downgrades Riverstone to 'neutral' due to lower earnings estimates and Covid-19 restrictions - THE EDGE SINGAPORE

Broker's Calls

RHB downgrades Riverstone to 'neutral' due to lower earnings estimates and Covid-19 restrictions

RHB Group Research has downgraded Riverstone to a target price of $1.30 from $1.85.
×